AtaCor Medical, Inc.

AtaCor Medical, Inc. is a medical device company based in San Clemente, California, founded in 2014. The company specializes in cardiac rhythm management solutions, focusing on innovative technologies that enhance patient care. AtaCor develops extravascular pacing and defibrillation leads that do not require vascular access or imaging for insertion, making the procedures less invasive and safer for patients. Their flagship product is the extracardiac pacing lead, designed for easy insertion outside the heart and vascular system. This approach minimizes complications associated with traditional leads, such as vascular injury and discomfort, while improving patient mobility and recovery. AtaCor is also advancing the Atala™ Extravascular Implantable Cardioverter Defibrillator (EV-ICD) Lead System, which aims to provide effective therapies without direct contact with cardiac tissue. The company is currently conducting the ASCEND EV clinical study to assess the safety and performance of this system. With a team that has over 80 years of combined experience in the field, AtaCor Medical is committed to developing solutions that enhance the safety and effectiveness of cardiac pacing and defibrillation therapies.

• Employees 23
• Founded 2014
• Annual Revenue $5200000
• Total Funding $62000000